An IV infusion clinic in Cullman has been court ordered to temporarily close its doors after being accused of administering ...
Matisse Pharmaceuticals B.V. was founded in 2014 in Geleen, the Netherlands. Matisse is dedicated to develop a product ...
Unapproved peptide drugs have become a trendy new approach to building muscle, smoothing wrinkles and trying to live longer.
WIAT Birmingham on MSN
Cullman IV infusion clinic closed indefinitely, accused of administering weight loss medications unsafe for humans
Target's new smile policy disrespects its employees — and the shoppers who left ...
Pertuzumab-dpzb is now considered an interchangeable biosimilar to pertuzumab as part of treatment combinations in multiple ...
Pertuzumab-dpzb is the first interchangeable biosimilar to pertuzumab, enhancing treatment accessibility for HER2-positive ...
Here are five examples of wellness trends that borrow from mainstream medicine. Ozone (O₃) is a form of oxygen. Ordinary ...
Here are five examples of wellness trends that borrow from mainstream medicine. Ozone (O₃) is a form of oxygen. Ordinary ...
Clinical Trials Arena on MSN
Matisse reports positive top line data from Phase I trial of M6229
In January 2024, Matisse reported positive topline results from the HistoSeps trial, which was designed to evaluate the ...
MedPage Today on MSN
Key HER2-Positive Breast Cancer Therapy Gets Its First Biosimilar
The FDA approved pertuzumab-dpzb (Poherdy) as the first biosimilar for its reference product Perjeta, a monoclonal antibody commonly used in standard regimens for HER2-positive breast cancer. FDA ...
Orion Infusion Limited has announced plans to invest Tk20.5 crore, including working capital, to expand its intravenous (IV) fluids production line in response to growing domestic demand.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback